Thus, in cancer cells, OGT is likely to exert its full activity without being restricted by substrate limitation, which would positively correlate the OGT protein level with the O-GlcNAcylation activity, the NRF1 protein level, and the expression levels of proteasome subunit genes. The gene discussed is OGT; the disease is cancer.